Survivin, an important antiapoptotic protein, is expressed in tumors, whereas in normal tissues the expression of this protein is extremely low, defining a role for survivin as a cancer gene. Survivin exhibits multifunctional activity in tumor cells. However, why survivin expression is sharply and invariably restricted to tumor tissue remains unclear. Here, we identified 11 putative consensus binding sites for GLI transcription factors in the survivin promoter and characterized the promoter activity. Inhibitors of the Hedgehog/GLI pathway, cyclopamine and GANT61, decreased the promoter activity in reporter assays. ΔNGLI2 (which lacks the repressor domain) was the most potent vector in activating the survivin promoter-reporter. Moreover, GANT61, a GLI1/2 inhibitor, repressed endogenous survivin protein and mRNA expression in most cells across a large panel of tumor cell lines. Chromatin immunoprecipitation showed GLI2 binding to the survivin promoter. The ectopic GLI2-evoked expression of endogenous survivin was observed in normal human fibroblasts. GANT61 decreased survivin level in nude mice tumors, mimicking the activity of GANT61 in cultured cells. The immunohistochemistry and double immunofluorescence of human tumors revealed a correlation between the tissue regions showing high GLI2 and survivin positivity. Thus, these results demonstrated that survivin is a classical transcriptional target of GLI2, a Hedgehog pathway signaling effector. This potentially reflects the high expression of survivin in human tumor cells. As the Hedgehog pathway is upregulated in virtually all types of cancer cells, these findings substantially contribute to the explanation of uniform survivin expression in tumors as a potential target for the development of a more effective treatment of cancers through the inhibition of GLI2 to restrain survivin activity.

Institute of Biophysics and Informatics Charles University Prague 1st Faculty of Medicine Prague Czech Republic

Institute of Pathology Charles University Prague 1st Faculty of Medicine and General University Hospital Prague Prague Czech Republic

Laboratory of Transcription and Cell Signaling Institute of Medical Biochemistry and Laboratory Diagnostics Charles University Prague 1st Faculty of Medicine Prague Czech Republic

Zobrazit více v PubMed

Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998; 152: 43–49. PubMed PMC

Altieri DC. New wirings in the survivin networks. Oncogene 2008; 27: 6276–6284. PubMed PMC

Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917–921. PubMed

Li F, Altieri DC. Transcriptional analysis of human survivin gene expression. Biochem J 1999; 344(Pt 2): 305–311. PubMed PMC

Xu R, Zhang P, Huang J, Ge S, Lu J, Qian G. Sp1 and Sp3 regulate basal transcription of the survivin gene. Biochem Biophys Res Commun 2007; 356: 286–292. PubMed

Boidot R, Vegran F, Lizard-Nacol S. Transcriptional regulation of the survivin gene. Mol Biol Rep 2014; 41: 233–240. PubMed

Dong Z, Yang L, Lai D. KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression. Cell Prolif 2013; 46: 425–435. PubMed PMC

Li Y, Xie M, Yang J, Yang D, Deng R, Wan Y et al. The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter. Oncogene 2006; 25: 3296–3306. PubMed PMC

Pandolfi S, Montagnani V, Lapucci A, Stecca B. HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth. Cell Death Differ 2015; 22: 2006–2019. PubMed PMC

Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes Dev 2008; 22: 2454–2472. PubMed

Marini KD, Payne BJ, Watkins DN, Martelotto LG. Mechanisms of Hedgehog signalling in cancer. Growth Factors 2011; 29: 221–234. PubMed

Ryan KE, Chiang C. Hedgehog secretion and signal transduction in vertebrates. J Biol Chem 2012; 287: 17905–17913. PubMed PMC

Riobo NA, Lu K, Emerson CP Jr. Hedgehog signal transduction: signal integration and cross talk in development and cancer. Cell Cycle 2006; 5: 1612–1615. PubMed

Lauth M, Toftgard R. Non-canonical activation of GLI transcription factors: implications for targeted anti-cancer therapy. Cell Cycle 2007; 6: 2458–2463. PubMed

Robbins DJ, Fei DL, Riobo NA. The Hedgehog signal transduction network. Sci Signal 2012; 5: re6. PubMed PMC

Aberger F, Ruiz I. Altaba. Context-dependent signal integration by the GLI code: the oncogenic load, pathways, modifiers and implications for cancer therapy. Semin Cell Dev Biol 2014; 33: 93–104. PubMed PMC

Riobo NA, Lu K, Ai X, Haines GM, Emerson CP Jr. Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proc Natl Acad Sci USA 2006; 103: 4505–4510. PubMed PMC

Stecca B, Mas C, Clement V, Zbinden M, Correa R, Piguet V et al. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sci USA 2007; 104: 5895–5900. PubMed PMC

Agarwal NK, Qu C, Kunkalla K, Liu Y, Vega F. Transcriptional regulation of serine/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog 1. J Biol Chem 2013; 288: 15390–15401. PubMed PMC

Lauth M, Bergstrom A, Shimokawa T, Tostar U, Jin Q, Fendrich V et al. DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS. Nat Struct Mol Biol 2010; 17: 718–725. PubMed

Mangelberger D, Kern D, Loipetzberger A, Eberl M, Aberger F. Cooperative Hedgehog-EGFR signaling. Front Biosci (Landmark Ed) 2012; 17: 90–99. PubMed PMC

Eberl M, Klingler S, Mangelberger D, Loipetzberger A, Damhofer H, Zoidl K et al. Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells. EMBO Mol Med 2012; 4: 218–233. PubMed PMC

Das S, Tucker JA, Khullar S, Samant RS, Shevde LA. Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases. PLoS One 2012; 7: e34374. PubMed PMC

Xu X, Zhou Y, Xie C, Wei SM, Gan H, He S et al. Genome-wide screening reveals an EMT molecular network mediated by Sonic hedgehog-Gli1 signaling in pancreatic cancer cells. PLoS One 2012; 7: e43119. PubMed PMC

Mazumdar T, Sandhu R, Qadan M, DeVecchio J, Magloire V, Agyeman A et al. Hedgehog signaling regulates telomerase reverse transcriptase in human cancer cells. PLoS One 2013; 8: e75253. PubMed PMC

Xu Y, An Y, Wang X, Zha W, Li X. Inhibition of the Hedgehog pathway induces autophagy in pancreatic ductal adenocarcinoma cells. Oncol Rep 2014; 31: 707–712. PubMed

Gonnissen A, Isebaert S, Haustermans K. Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened. Oncotarget 2015; 6: 13899–13913. PubMed PMC

Srivastava RK, Kaylani SZ, Edrees N, Li C, Talwelkar SS, Xu J et al. GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis. Oncotarget 2014; 5: 12151–12165. PubMed PMC

Matsumoto T, Tabata K, Suzuki T. The GANT61, a GLI inhibitor, induces caspase-independent apoptosis of SK-N-LO cells. Biol Pharm Bull 2014; 37: 633–641. PubMed

Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Philpott MP et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res 2004; 64: 7724–7731. PubMed

Das S, Harris LG, Metge BJ, Liu S, Riker AI, Samant RS et al. The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin. J Biol Chem 2009; 284: 22888–22897. PubMed PMC

Lauth M, Bergstrom A, Shimokawa T, Toftgard R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA 2007; 104: 8455–8460. PubMed PMC

Winklmayr M, Schmid C, Laner-Plamberger S, Kaser A, Aberger F, Eichberger T et al. Non-consensus GLI binding sites in Hedgehog target gene regulation. BMC Mol Biol 2010; 11: 2–9. PubMed PMC

Roessler E, Ermilov AN, Grange DK, Wang A, Grachtchouk M, Dlugosz AA et al. A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2. Hum Mol Genet 2005; 14: 2181–2188. PubMed

Tsanev R, Tiigimagi P, Michelson P, Metsis M, Osterlund T, Kogerman P. Identification of the gene transcription repressor domain of Gli3. FEBS Lett 2009; 583: 224–228. PubMed PMC

Sasaki H, Nishizaki Y, Hui C, Nakafuku M, Kondoh H. Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. Development 1999; 126: 3915–3924. PubMed

Teglund S, Toftgard R. Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta 2010; 1805: 181–208. PubMed

Rodriguez-Blanco J, Schilling NS, Tokhunts R, Giambelli C, Long J, Liang FD et al. The hedgehog processing pathway is required for NSCLC growth and survival. Oncogene 2013; 32: 2335–2345. PubMed PMC

Yang L, Xie G, Fan Q, Xie J. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene 2010; 29: 469–481. PubMed

Bigelow RL, Chari NS, Unden AB, Spurgers KB, Lee S, Roop DR et al. Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J Biol Chem 2004; 279: 1197–1205. PubMed

Xu XF, Guo CY, Liu J, Yang WJ, Xia YJ, Xu L et al. Gli1 maintains cell survival by up-regulating IGFBP6 and Bcl-2 through promoter regions in parallel manner in pancreatic cancer cells. J Carcinog 2009; 8: 13. PubMed PMC

Bar EE, Chaudhry A, Farah MH, Eberhart CG. Hedgehog signaling promotes medulloblastoma survival via Bc/II. Am J Pathol 2007; 170: 347–355. PubMed PMC

Safe S, Abdelrahim M. Sp transcription factor family and its role in cancer. Eur J Cancer 2005; 41: 2438–2448. PubMed

Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP et al. A paracrine requirement for hedgehog signalling in cancer. Nature 2008; 455: 406–410. PubMed

Atwood SX, Chang AL, Oro AE. Hedgehog pathway inhibition and the race against tumor evolution. J Cell Biol 2012; 199: 193–197. PubMed PMC

Ondrusova L, Vachtenheim J, Reda J, Zakova P, Benkova K. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells. PLoS One 2013; 8: e54110. PubMed PMC

Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL et al. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 2000; 10: 1319–1328. PubMed

Brun SN, Markant SL, Esparza LA, Garcia G, Terry D, Huang JM et al. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma. Oncogene 2015; 34: 3770–3779. PubMed PMC

The Hedgehog/GLI signaling pathway activates transcription of Slug (Snail2) in melanoma cells

Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy